Introduction to Molecular Tumor Boards in Precision Oncology

Modern cancer care increasingly relies on genomic profiling, but translating complex genetic data into actionable treatment plans requires a structured, collaborative approach. This text-based course guides you through the foundational concepts of precision oncology and the critical role of the Molecular Tumor Board in clinical decision-making. You will transition from understanding basic genomic variants to recognizing how clinical teams collaborate to select targeted therapies. What you'll learn: Understand the fundamental terminology of cancer genomics and molecular profiling; Identify key biomarkers, including next-generation sequencing results, tumor mutational burden, and microsatellite instability; Analyze how molecular tumor boards evaluate genetic variants to make evidence-based treatment recommendations; Explore the role of liquid biopsies and modern diagnostic tools in tracking tumor evolution; Practice interpreting mock clinical case studies and variant databases through structured written exercises. The course starts with essential definitions of genomic alterations before moving into diagnostic technologies, variant interpretation guidelines, and simulated case discussions. Designed for healthcare professionals, medical students, life science graduates, and anyone seeking a clear, beginner-friendly introduction to precision oncology, no prior advanced genetics background is required. Begin your journey into the future of personalized cancer care today.